UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency
- Posted on June 17, 2026
- By CNBC
- 0 Views
- 1 min read
UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
